Events
![](/upload/resize_cache/iblock/593/386_220_2/593b2b2d47d186c50792461b50d3b0c0.jpg)
Press Center
![](/upload/resize_cache/iblock/152/140_80_2/152178863ab83cde099a045fcbed27f9.jpg)
12.05.2014
The immunobiological production unit of NPO Petrovax Pharm, a Russian pharmaceutical company, has produced more than 2.5 mln doses of Prevenar 13, a 13-valent conjugate pneumococcal vaccine, in easy to use disposable auto injectors. More than 5 mln doses are planned to be produced by the end of 2014.
More
Topics Petrovax Pharm